Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth

NCT01632020 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Inadequate accrual

Conditions

Colorectal Neoplasms

Interventions

DRUG: Placebo
DRUG: Metformin

Sponsor

University of Arkansas